NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 358 filers reported holding NOVOCURE LTD in Q4 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $91,000 | -19.5% | 1,315 | -3.6% | 0.02% | -10.0% |
| Q1 2022 | $113,000 | +8.7% | 1,364 | -1.1% | 0.02% | +17.6% |
| Q4 2021 | $104,000 | -36.6% | 1,379 | -2.1% | 0.02% | -41.4% |
| Q3 2021 | $164,000 | -47.8% | 1,409 | -0.4% | 0.03% | -49.1% |
| Q2 2021 | $314,000 | +1552.6% | 1,414 | +895.8% | 0.06% | +1325.0% |
| Q1 2021 | $19,000 | -24.0% | 142 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $25,000 | +56.2% | 142 | 0.0% | 0.01% | +20.0% |
| Q3 2020 | $16,000 | +100.0% | 142 | 0.0% | 0.01% | +66.7% |
| Q2 2020 | $8,000 | 0.0% | 142 | +14.5% | 0.00% | -25.0% |
| Q1 2020 | $8,000 | – | 124 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $39,681,000 | 20.12% |
| HARTLINE INVESTMENT CORP/ | 330,672 | $27,866,000 | 5.97% |
| MORGAN JESS S & CO INC | 52,889 | $4,457,000 | 4.37% |
| Darsana Capital Partners LP | 1,350,000 | $113,765,000 | 3.88% |
| Rhenman & Partners Asset Management AB | 350,000 | $29,495,000 | 3.23% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $843,000 | 2.55% |
| Taylor Frigon Capital Management LLC | 38,073 | $3,208,000 | 2.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,500 | $2,991,000 | 1.08% |
| Granite Investment Partners, LLC | 261,315 | $22,021,000 | 1.04% |
| Nicholas Investment Partners, LP | 85,835 | $7,233,000 | 0.74% |